- NEW YORK STATE COMMON RETIREMENT FUND$527.2K
- Alpha Zero LLC$19.6K
BioXcel Therapeutics Inc NASDAQ NMS - GLOBAL MARKET:BTAI
Institutional holders, quarter-over-quarter share deltas, and new and closed positions disclosed in Form 13F. Period 2025-09-30 · prior 2025-06-30.
New Positions(2)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| NEW YORK STATE COMMON RETIREMENT FUND | 34,430 | +34,430 | $527.2K | +$527.2K | — |
| Alpha Zero LLC | 52,350 | +52,350 | $19.6K | +$19.6K | — |
Sold Out(2)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| DEUTSCHE BANK AG\ | 0 | -17,537 | $0 | -$49.5K | — |
| ADVISOR GROUP HOLDINGS, INC. | 0 | -14,875 | $0 | -$5.5K | — |
Top Holders by reported value
Ranked by the dollar value reported on the latest Form 13F. Share counts reflect long positions as of 2025-09-30.
| Manager | Shares | $ Value | Δ Shares | QoQ % |
|---|---|---|---|---|
| NEW YORK STATE COMMON RETIREMENT FUND | 34,430 | $527.2K | +34,430 | — |
| Alpha Zero LLC | 52,350 | $19.6K | +52,350 | — |
New & Closed Positions this quarter
Methodology
Form 13F is the SEC's quarterly disclosure for institutional investment managers exercising discretion over $100 million or more in qualifying U.S. equity securities. Managers must file within 45 days of each calendar quarter end, which is why holdings shown here reflect a snapshot at the period date — not real-time positioning.
Quarter-over-quarter deltas compare each manager's most recently reported share count for BTAI against its prior-quarter count. New positions are entries where the prior count was zero; closed positions are entries where the current count is zero. Amendments (13F-HR/A) replace prior filings for the same period.
Source: SEC EDGAR Form 13F (XML information tables). Dollar values are as reported by the manager and may use mid-quarter pricing conventions. CUSIP-to-ticker resolution is best-effort.